27 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
disability insurance; and life insurance. We believe the perquisites described above are necessary and appropriate to provide a competitive compensation
8-K
EX-10.1
nan9t6kc
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-10.1
6cuw2qbw0q4puu wsan
1 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
bgqmhor
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
424B5
fkzwzeucgquuap34h7u
11 Aug 22
Prospectus supplement for primary offering
5:09pm
424B5
iu93r 5ymwj1j
9 Aug 22
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
vhn8 k57n2s7p
11 Aug 21
Departure of Directors or Certain Officers
4:27pm
S-3
i9vgenwyzq22ijfc
19 Mar 21
Shelf registration
5:23pm
POS AM
8otvi1ca82qltf
19 Mar 21
Prospectus update (post-effective amendment)
4:56pm
DEF 14A
4lgf1j19tc0flka
19 Mar 21
Definitive proxy
4:02pm
10-K
EX-4.5
lksgo6
25 Feb 21
Annual report
8:29am
6-K
EX-1
8xdhe4 n1xk2hv
30 Dec 20
Current report (foreign)
4:11pm
6-K
EX-3
hptkae4a huntmen0
12 Nov 20
Current report (foreign)
6:40am
F-1
EX-10.12
73i87b
17 Aug 20
Registration statement (foreign)
6:41am
6-K
EX-1
cycx9gcknfmxdnank
22 Jul 20
Current report (foreign)
4:05pm